Search Constraints
Filtering by:
Date
2011
Remove constraint Date: 2011
Department, School or Faculty
Strathclyde Institute of Pharmacy and Biomedical Sciences.
Remove constraint Department, School or Faculty: Strathclyde Institute of Pharmacy and Biomedical Sciences.
1 - 37 of 37
Number of results to display per page
Search Results
Select an image to start the slideshow
Design and synthesis of IKK1 inhibitors for the treatment of hormone refractory prostate cancer
1 of 37
Forensic toxicology of gamma hydroxybutyrate (GHB) metabolism
2 of 37
Preparation and evaluation of amino acid-bearing polymers for enhanced gene expression in tumours
3 of 37
Formulation of bacteriophage for application in bacterial lung infection
4 of 37
A model for continuous quality improvement of medication use, concepts, methods and applications
5 of 37
The role of phospholipids in streptomycete growth and differentiation
6 of 37
The role of adventitia in pressure-dependent myogenic tone
7 of 37
A comparison of the effects of IGFBP-5 and TGF-b1 on epithelial and mesenchymal cell adhesion, migration and survival
8 of 37
Total synthesis and semi-synthesis of lipid and protein components of Mycobacterium tuberculosis
9 of 37
Design and evaluation of bacteriophage production for potential commercial use
10 of 37
Discovery and characterisation of novel anticancer compounds acting on sphingosine kinase
11 of 37
Molecular mechanisms of cell proliferation in endometriosis
12 of 37
Analysis of the phytochemical composition and anti-inflammatory properties of Lovage
13 of 37
Use of a novel in vitro technique to investigate needle-induced vascular injury and its pharmacological regulation
14 of 37

The effect of precipitation techniques on bioadhesive microparticle characteristics
15 of 37
The design and synthesis of inhibitors of the mitotic human kinesin, Eg5
16 of 37
Non-ionic surfactant vesicles as a delivery system for cisplatin
17 of 37
Understanding the role of IGFBP-5 on epithelial and mesenchymal cell adhesion, migration, survival and boundary integrity with a novel 'in vitro' 2D co-culture model
18 of 37
Evaluation of antioxidants encapsulated nanoparticles in animal models
19 of 37
Deep brain stimulation of the mediodorsal thalmic nucleus and its implications for the treatment of schizophrenia
20 of 37
Development of DPP-IV inhibitors for the treatment of type 2 diabetes
21 of 37
Imaging of dermal formulations using Raman microscopy techniques
22 of 37
Application of matrix-assisted laser desorption/ionisation (MALDI) imaging mass spectrometry and high resolution Fourier transform mass spectrometry for profiling pharmaceuticvals and biomarkers in a variety of biological samples
23 of 37
Examination of the anti-inflammatory properties of the herb Lovage
24 of 37
Leishmania mexicana phosphoproteomics
25 of 37
Metabolomic profiling of Streptomyces coelicolor wild type and mutant strains lacking glutamine synthetase genes using Orbitrap mass spectrometry
26 of 37
Optimising nasal formulations for antimicrobial drug delivery
27 of 37
Investigating the role of lymphocytes in in vitro models of neurodegenerative disease
28 of 37
Activities of extracts and constituents of two Libyan ornamental plants relevant to anti-inflammatory activity
29 of 37
Control of human inflammatory and cell response by novel and classical steroids
30 of 37
The impact of physicochemical properties and physiological clearance mechanisms on ocular drug distribution
31 of 37
Intranasal, inhaled and oral corticosteroids and side effects in asthma, rhinitis and nasal polyposis
32 of 37
Production of novel amine oxidases from microorganisms
33 of 37
The potential of polymeric nanoparticles for oral delivery of Amphotericin B, preparation, scale-up, in vitro and in vivo evaluation
34 of 37
Electrophysiological and neurochemical investigation into the effects of cannabidiol in the CNS
35 of 37
Oral drug delivery of cyclosporine-A using mesoporous silica particles
36 of 37
Elucidating the function of a conserved gene cluster in a non-pathogenic actinomycete
37 of 37